Analysis backs combined hormone therapy, breast cancer link

04/1/2013 | HealthDay News

An analysis of data from the Women's Health Initiative found that postmenopausal women who took estrogen and progestin were more likely to develop breast cancer. The risk of breast cancer was about three times higher among women who started taking the hormones within months of menopause compared with those who waited 10 years. The study appeared in the Journal of the National Cancer Institute.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID